Medicine and Dentistry
Neoplasm
100%
Diseases
64%
Malignant Neoplasm
63%
Surgery
59%
Recurrent Disease
44%
Overall Survival
40%
Breast Cancer
39%
Radiation Therapy
39%
Metastatic Carcinoma
37%
Cancer
30%
Ovarian Cancer
27%
Melanoma
25%
Surgeon
20%
Neck
17%
Chemoradiotherapy
16%
Lymph Node
15%
Neoadjuvant Chemotherapy
15%
Prostate Cancer
14%
Retroperitoneal Lymph Node Dissection
14%
Clinical Trial
14%
Cancer Cell
14%
Hazard Ratio
13%
Squamous Cell Carcinoma
13%
Primary Tumor
12%
Biopsy Technique
12%
Survival Rate
12%
Uterine Cancer
12%
Cervical Cancer
12%
Head and Neck Cancer
12%
Adenocarcinoma
12%
Krukenberg Tumor
11%
Oncology
11%
Lung Cancer
11%
Bladder Cancer
11%
Biological Marker
10%
Carcinoma
10%
Colorectal Carcinoma
10%
Pancreas Cancer
10%
Breast Reconstruction
10%
Prognostic Factor
10%
Immunotherapy
10%
Progression Free Survival
9%
Systemic Therapy
9%
Clear Cell Renal Cell Carcinoma
9%
Quality of Life
9%
Magnetic Resonance Imaging
9%
Odds Ratio
9%
Transitional Cell Carcinoma
9%
Tumor Progression
9%
Non Small Cell Lung Cancer
9%
Health Care Cost
9%
Pancreas Adenocarcinoma
8%
Hepatectomy
8%
Systematic Review
8%
Pelvis
8%
Cancer Therapy
8%
Disease Free Survival
8%
Tumor Cell
8%
Adjuvant Therapy
8%
Free Tissue Graft
8%
Neoadjuvant Therapy
8%
Cisplatin
7%
Cancer Staging
7%
Rectum Cancer
7%
Diagnosis
7%
Sentinel Lymph Node
7%
Programmed Cell Death
7%
Multivariate Analysis
7%
In Vitro
7%
Connective Tissue Cancer
7%
Soft Tissue Sarcoma
7%
Targeted Therapy
7%
Mastectomy
7%
Lymph Node Metastasis
7%
Cystectomy
7%
Protein P53
7%
Wart Virus
6%
Gynecological Oncology
6%
Immunity
6%
Surgical Technique
6%
Ganglioglioma
6%
Distant Metastasis
6%
Colorectal Liver Metastasis
6%
Glioblastoma
6%
Oropharynx Carcinoma
6%
Proportional Hazards Model
6%
Sentinel Lymph Node Biopsy
6%
Computer Assisted Tomography
6%
Cytoreductive Surgery
6%
Brain Metastasis
6%
Recurrence Free Survival
6%
Cancer Surgery
6%
Meta-Analysis
5%
Female Genital Tract Cancer
5%
Postoperative Complication
5%
Abdominal Cancer
5%
Esophageal Cancer
5%
Vasculotropin
5%
Arm
5%
Disease Specific Survival
5%
Keyphrases
Tumor
37%
Overall Survival
25%
Confidence Interval
17%
Chemotherapy
16%
Ovarian Cancer
13%
Breast Cancer
12%
Neoadjuvant Chemotherapy
11%
Melanoma
11%
Head-and-neck
11%
Hazard Ratio
10%
Resection
10%
Radiation Therapy
10%
Radiotherapy
10%
Metastasis
9%
Head-and-neck Cancer
8%
In Cancer
7%
Clinical Trials
7%
Colorectal Cancer
7%
Bladder Cancer
7%
High Risk
7%
Apoptosis
7%
Odds Ratio
7%
Non-small Cell Lung Cancer (NSCLC)
7%
Cancer Patients
6%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
6%
Prognostic Factors
6%
Primary Tumor
6%
Tumor Cells
6%
Progression-free Survival
6%
Breast Reconstruction
6%
Disease-free Survival
6%
Surgical Resection
6%
Prostate Cancer
6%
Breast Cancer Patients
6%
Endometrial Cancer
6%
Combined Modality Therapy
6%
Clinical Outcomes
6%
Cisplatin
5%
Neoadjuvant Therapy
5%
Metastatic Melanoma
5%
Recurrent Disease
5%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
5%
Distant Metastasis
5%
Pathological Complete Response
5%
Adjuvant Therapy
5%
Malignancy
5%
Sentinel Lymph Node Biopsy
5%
Colorectal Liver Metastases
5%
Metastatic Disease
5%
Multivariate Analysis
5%
Systemic Therapy
5%
Local Recurrence
5%
Cancer Cells
5%
Neoadjuvant
5%
Tumor Growth
5%
Patient Selection
5%
Targeted Therapy
5%
Pancreatic Cancer
5%
Phase II Trial
5%
5-year Survival
5%
Renal Cell Carcinoma
5%
Cervical Cancer
5%